Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

18
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
18
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

154
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
154
Inflammation01:38

Inflammation

53.7K
Overview
53.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconsidering the Term "Patient" in Alcohol and Other Drug Treatment Settings.

Substance use & addiction journal·2026
Same author

Virtual-Only or In-Person Interviews for Residency Applicants.

The New England journal of medicine·2026
Same author

Anemia and elevated hemoglobin in stroke patients treated with thrombectomy - a cohort study from the EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients collaboration.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Limited representation of authors from low- and middle-income countries in trials with participants from LMICs across 15 years (2008-2023).

Journal of clinical epidemiology·2026
Same author

Association between aldehyde dehydrogenase 4 family member A1 plasma concentrations and atherosclerotic disease in patients with ischemic stroke: Results from the prospective multicenter BIOSIGNAL study.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Blood pressure management in patients receiving rescue stenting after failed endovascular treatment in large vessel occlusion acute ischaemic stroke: a multicentre registry.

European stroke journal·2026
Same journal

Advancing engagement of people with lived experience of stroke in recovery and rehabilitation research: Consensus-based core recommendations from the fourth Stroke Recovery and Rehabilitation Roundtable.

International journal of stroke : official journal of the International Stroke Society·2026
Same journal

The first-ever World Health Organisation (WHO) resolution on stroke, climate change and stroke, and do illicit drugs increase stroke risk.

International journal of stroke : official journal of the International Stroke Society·2026
Same journal

Global epidemiology of atrial fibrillation and atrial flutter: an increasing worldwide burden.

International journal of stroke : official journal of the International Stroke Society·2026
Same journal

Stroke in South-Asian Populations: Unique Susceptibility, Risk Factors, and Treatment Considerations.

International journal of stroke : official journal of the International Stroke Society·2026
Same journal

Stroke in Pregnancy.

International journal of stroke : official journal of the International Stroke Society·2026
Same journal

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

International journal of stroke : official journal of the International Stroke Society·2026
See all related articles

Related Experiment Video

Updated: Jul 14, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

2.1K

Targeting inflammation to reduce recurrent stroke.

Annaelle Zietz1,2, Sarah Gorey3,4,5, Peter J Kelly3,4,6

  • 1Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.

International Journal of Stroke : Official Journal of the International Stroke Society
|October 6, 2023
PubMed
Summary
This summary is machine-generated.

Inflammation plays a key role in various stroke types and recurrent vascular events. Identifying patients with residual inflammatory risk using biomarkers can guide future anti-inflammatory therapies for secondary stroke prevention.

Keywords:
Strokeinflammationinflammatory biomarkersstroke etiologystroke prevention

More Related Videos

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.1K
Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery
07:26

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Published on: May 24, 2021

7.2K

Related Experiment Videos

Last Updated: Jul 14, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

2.1K
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.1K
Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery
07:26

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Published on: May 24, 2021

7.2K

Area of Science:

  • Neuroscience
  • Immunology
  • Cardiology

Background:

  • Recurrent vascular events affect approximately 25% of stroke patients, necessitating improved secondary prevention.
  • Inflammation is a known factor in coronary atherosclerosis, but its role across diverse stroke subtypes is not fully understood.
  • Understanding inflammation's prognostic value by stroke subtype is crucial for designing effective randomized control trials (RCTs) for anti-inflammatory therapies.

Purpose of the Study:

  • To review inflammatory pathways in ischemic stroke subtypes.
  • To examine the association between inflammatory markers and vascular recurrence post-stroke.
  • To evaluate RCT evidence for anti-inflammatory agents in vascular prevention.

Main Methods:

  • Narrative review of experimental, genetic, and imaging studies.
  • Analysis of evidence linking inflammatory markers (e.g., IL-6, hsCRP) to stroke recurrence.
  • Review of RCTs investigating anti-inflammatory therapies for vascular risk reduction.

Main Results:

  • Inflammation is implicated in atherosclerotic stroke, small vessel disease (neuroinflammation), and atrial fibrillation.
  • Interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) show promise in identifying high-risk patients.
  • Anti-inflammatory therapies have demonstrated vascular risk reduction in coronary artery disease, with ongoing trials for stroke prevention.

Conclusions:

  • Inflammation is important across multiple stroke etiologies, suggesting potential benefits from anti-inflammatory strategies.
  • Biomarkers can identify patients with residual inflammatory risk for targeted secondary stroke prevention.
  • Biomarker-led patient selection is recommended for future RCTs evaluating anti-inflammatory treatments.